id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0336-0031,FDA,FDA-1975-N-0336,Request for Hearing with Supporting Information Regarding Proposed Withdrawal of Approved Applications for Anticholinergic and Barbiturate Combination Drug Products - Supplemental Information (Vol. 141-B),Other,Request for Hearing,2011-09-13T04:00:00Z,2011,9,2011-09-13T04:00:00Z,,2017-12-05T21:44:07Z,,0,0,0900006480ee57db
FDA-1975-N-0336-0027,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Premo Pharmaceutical Labs, Inc.,  - [Sheppard Mulln Richter & Hampton LLP]  DESI 10837 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-07T22:36:20Z,,1,0,0900006480f08fee
FDA-1975-N-0336-0015,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Poythress Laboratories, Inc., DESI 597 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T19:38:48Z,,0,0,0900006480f08da7
FDA-1975-N-0336-0030,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Cord Labs, Inc., - [Arent Fox LLP]  DESI 10837 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T19:49:09Z,,0,0,0900006480f08ff6
FDA-1975-N-0336-0024,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Beecham Laboratories, DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T19:46:03Z,,0,0,0900006480f08fb3
FDA-1975-N-0336-0026,FDA,FDA-1975-N-0336,FDA/CDER Letter to Premo Pharmaceutical. - [Teva Pharmaceuticals]  DESI 10837 - Letter,Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-12T05:03:05Z,,1,0,0900006480f08fb7
FDA-1975-N-0336-0017,FDA,FDA-1975-N-0336,"FDA/CDER Letter to  Reid-Provident Laboratories, Inc.'s., DESI 597  [ Abbott Laboratories] - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-07T22:36:37Z,,1,0,0900006480f08ede
FDA-1975-N-0336-0019,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-07T22:36:31Z,,1,0,0900006480f08ee2
FDA-1975-N-0336-0023,FDA,FDA-1975-N-0336,"FDA/CDER Letter to B.F. Ascher & Co., Inc., DESI 597 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-12T05:03:05Z,,1,0,0900006480f08f95
FDA-1975-N-0336-0025,FDA,FDA-1975-N-0336,"FDA/CDER Letter to  Richlyn Laboratories, Inc.., - [Impax Laboratories, Inc.]  DESI 597 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-12T05:03:05Z,,1,0,0900006480f08fb5
FDA-1975-N-0336-0021,FDA,FDA-1975-N-0336,"FDA/CDER Letter to West-Ward Pharmaceutical Corp., DESI 597 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2013-01-08T03:27:35Z,,0,0,0900006480f08f91
FDA-1975-N-0336-0014,FDA,FDA-1975-N-0336,"FDA/CDER Letter to National  Pharmaceuticals Manufacturing Co.,, DESI 597 - [ Actavis US] - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-07T22:36:30Z,,1,0,0900006480f08da5
FDA-1975-N-0336-0016,FDA,FDA-1975-N-0336,FDA/CDER Letter to Purepac Pharmaceutical's - [ Actavis ] - Letter,Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T19:39:08Z,,0,0,0900006480f08edc
FDA-1975-N-0336-0022,FDA,FDA-1975-N-0336,"FDA/CDER Letter to William Rorer, Inc., DESI 597 [ Sanofi-aventis U,S.] - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-12T05:03:04Z,,1,0,0900006480f08f93
FDA-1975-N-0336-0020,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Stuart Pharmaceuticals, DESI 597 - [ AstraZeneca Pharmaceuticals LP] - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T19:42:14Z,,0,0,0900006480f08f8d
FDA-1975-N-0336-0028,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Roche pharmaceutical, - [Genentech, Inc.] - DESI 10837 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T19:48:23Z,,0,0,0900006480f08ff0
FDA-1975-N-0336-0029,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Roche Laboratories, - [Valeant Pharmaceuticals International, Inc] - DESI 10837 - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-07T22:36:38Z,,1,0,0900006480f08ff4
FDA-1975-N-0336-0018,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter",Other,Letter(s),2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2024-11-07T22:36:30Z,,1,0,0900006480f08ee0
FDA-1975-N-0336-0012,FDA,FDA-1975-N-0336,"FDA/CDERLletter to Lemmon Co., DESI 597 - [ Teva Pharmaceuticals Co.] - Letter",Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2024-11-12T05:02:18Z,,1,0,0900006480f076b7
FDA-1975-N-0336-0006,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Carter-Wallace, Inc., DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter",Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2011-08-30T19:33:06Z,,0,0,0900006480f07671
FDA-1975-N-0336-0007,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Ferdale Pharma Group, Inc - Letter",Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2011-08-30T19:33:22Z,,0,0,0900006480f07678
FDA-1975-N-0336-0013,FDA,FDA-1975-N-0336,"FDA/CDER letter to McNeil Pharmaceuticals., DESI 597 - [ Ortho-McNeil-Janssen Pharmaceuticals Inc.] - Letter",Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2011-08-30T19:37:33Z,,0,0,0900006480f076ba
FDA-1975-N-0336-0009,FDA,FDA-1975-N-0336,FDA/CDER letter to Halsey Drug Co. - [ Acura Pharmaceuticals Co.] - Letter,Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2024-11-07T22:36:38Z,,1,0,0900006480f076a0
FDA-1975-N-0336-0011,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Lemmon Co., DESI 597 - [ Teva Pharmaceuticals Co.] - Letter",Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2024-11-07T22:36:30Z,,1,0,0900006480f076b2
FDA-1975-N-0336-0008,FDA,FDA-1975-N-0336,"FDA/CDER Letter to Halsey Drug Co., DESI 597 - [ Acura Pharmaceuticals Co.] - Letter",Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2011-08-30T19:33:37Z,,0,0,0900006480f0767c
FDA-1975-N-0336-0010,FDA,FDA-1975-N-0336,"FDA/CDER letter to Kremers-Urban Co. DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter",Other,Letter(s),2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2024-11-07T22:36:30Z,,1,0,0900006480f076a2
FDA-1975-N-0336-0005,FDA,FDA-1975-N-0336,"Letter from FDA CDER to Kleindeld, Kaplan & Becker LLP",Other,Letter(s),2011-08-25T04:00:00Z,2011,8,2011-08-25T04:00:00Z,,2017-11-13T18:35:08Z,,0,0,0900006480eeb8ed
FDA-1975-N-0336-0004,FDA,FDA-1975-N-0336,Request for Hearing with Supporting Information Regarding Proposed Withdrawal of Approved Applications for Anticholinergic and Barbiturate Combination Drug Products (Buchanan Ingersoll & Rooney PC) (Vol 141-A),Other,Request for Hearing,2011-08-11T04:00:00Z,2011,8,2011-08-11T04:00:00Z,,2017-12-05T21:41:21Z,,0,0,0900006480ec1a8d
FDA-1975-N-0336-0003,FDA,FDA-1975-N-0336,"FDA/OC to PMB Pharmaceuticals, Inc.(Buchanan Ingersoll & Rooney, PC) - Letter",Other,Letter(s),2011-08-09T04:00:00Z,2011,8,2011-08-09T04:00:00Z,,2011-08-09T19:57:46Z,,0,0,0900006480edc698
FDA-1975-N-0336-0001,FDA,FDA-1975-N-0336,"Letter from West-Ward Pharmaceutical Corporation and PBM Pharmaceutical, Inc. to FDA/CDER",Other,Letter(s),2011-07-14T04:00:00Z,2011,7,2011-07-14T04:00:00Z,,2017-12-06T15:37:11Z,,0,0,0900006480ebd5c8
FDA-1975-N-0336-0002,FDA,FDA-1975-N-0336,"Letter from PBM Pharmaceutical, Inc. (Buchanan Ingersoll and Rooney, PC) to FDA",Other,Letter(s),2011-07-14T04:00:00Z,2011,7,2011-07-14T04:00:00Z,,2017-12-06T15:54:22Z,,0,0,0900006480ebd5ca